Haleos Labs Limi

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE320X01016
  • NSEID: HALEOSLABS
  • BSEID: 540679
INR
1,510.00
-11 (-0.72%)
BSENSE

Jun 03, 03:30 PM

BSE+NSE Vol: 1.45 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
333.79
344.72
305.96
315.56
349.74
265.59
260.78
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
333.79
344.72
305.96
315.56
349.74
265.59
260.78
Raw Material Cost
146.69
149.91
150.19
171.33
204.47
135.17
147.04
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-8.18
4.15
0.97
0.08
-9.79
1.87
10.84
Employee Cost
65.38
59.54
52.26
43.43
39.90
30.66
26.56
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
66.43
65.55
57.63
56.59
65.08
50.21
40.30
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
18.80
20.53
13.79
15.38
15.93
17.51
10.66
Total Expenditure (Excl Depreciation)
289.12
299.68
274.84
286.81
315.59
235.42
235.40
Operating Profit (PBDIT) excl Other Income
44.67
45.04
31.12
28.75
34.15
30.17
25.38
Other Income
2.43
4.86
3.83
3.07
2.07
1.78
2.28
Operating Profit (PBDIT)
47.10
49.90
34.95
31.82
36.22
31.95
27.66
Interest
6.45
8.71
10.16
6.79
6.17
4.53
5.14
Exceptional Items
0.00
0.00
0.00
2.35
0.00
0.00
0.00
Gross Profit (PBDT)
40.65
41.19
24.79
27.38
30.05
27.42
22.52
Depreciation
15.47
15.00
14.94
10.79
10.01
7.86
7.86
Profit Before Tax
25.20
26.19
9.85
16.59
20.04
19.57
14.67
Tax
7.40
7.46
3.52
5.22
7.43
6.01
4.48
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.80
18.73
6.33
11.38
12.61
13.56
10.18
Extraordinary Items
0.00
0.00
0.00
0.00
12.69
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.80
18.73
6.33
11.38
25.30
13.56
10.18
Share in Profit of Associates
0.00
0.00
0.00
0.00
-0.02
0.00
0.00
Minority Interest
-0.49
1.38
2.77
0.09
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
17.31
20.11
9.09
11.46
25.28
13.56
10.18
Equity Capital
3.02
3.02
3.02
3.02
3.02
3.02
3.02
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
193.54
173.79
165.59
149.21
126.19
112.71
Earnings per share (EPS)
57.32
66.59
30.1
37.95
83.71
44.9
33.71
Diluted Earnings per share
57.26
66.51
30.08
30.53
49.9
44.84
33.68
Operating Profit Margin (Excl OI)
13.38%
13.07%
10.17%
9.11%
9.76%
11.36%
9.73%
Gross Profit Margin
12.18%
11.95%
8.1%
8.68%
8.59%
10.32%
8.64%
PAT Margin
5.33%
5.43%
2.07%
3.61%
3.61%
5.11%
3.9%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -3.17% vs 12.67% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is -13.92% vs 121.23% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -0.82% vs 44.73% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -25.95% vs -14.27% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of Haleos Labs Limi With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
333.79
0
333.79
Other Operating Income
0.00
0.00
0.00
Total Operating income
333.79
0
333.79
Raw Material Cost
146.69
0
146.69
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-8.18
0
-8.18
Employee Cost
65.38
0
65.38
Power Cost
0.00
0
0.00
Manufacturing Expenses
66.43
0
66.43
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
18.80
0.00
18.80
Total Expenditure (Excl Depreciation)
289.12
0
289.12
Operating Profit (PBDIT) excl Other Income
44.67
0.00
44.67
Other Income
2.43
0
2.43
Operating Profit (PBDIT)
47.10
0
47.10
Interest
6.45
0
6.45
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
40.65
0
40.65
Depreciation
15.47
0
15.47
Profit Before Tax
25.20
0
25.20
Tax
7.40
0
7.40
Provisions and contingencies
0.00
0
0.00
Profit After Tax
17.80
0
17.80
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
17.80
0
17.80
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-0.49
0
-0.49
Other related items
0.00
0.00
0.00
Consolidated Net Profit
17.31
0
17.31
Equity Capital
3.02
0
3.02
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
57.32
0
57.32
Diluted Earnings per share
57.26
0
57.26
Operating Profit Margin (Excl OI)
13.38%
0%
0.00
13.38%
Gross Profit Margin
12.18%
0%
0.00
12.18%
PAT Margin
5.33%
0%
0.00
5.33%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 333.79 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -3.17% vs 12.67% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 17.31 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -13.92% vs 121.23% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 44.67 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -0.82% vs 44.73% in Mar 2025

Annual - Interest
Interest 6.45 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -25.95% vs -14.27% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.38%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has improved from Mar 2025